Physician profile
James Waller
NPI 1366440299
$285.59
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $116 · 2021: $150 · 2022: $19.02.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $82.12 | 2020-2021 | |
| Integra Lifesciences Corporation | $43.77 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.52 | 2021 | |
| Axonics, INC. | $31.22 | 2020 | |
| Hollister Incorporated | $24.73 | 2021 | |
| Innocoll Pharmaceuticals Limited | $22.88 | 2021 | |
| Medtronic, INC. | $19.02 | 2022 | |
| Tela Bio, INC. | $13.94 | 2020 | |
| Stryker Corporation | $12.39 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Waller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.